[1]苗莉,缪竞诚.细胞因子在急性辐射损伤治疗中的作用[J].国际放射医学核医学杂志,2006,30(3):173-176.
 MIAO Li,MIAO Jing-cheng.Effects of cytokine on acute radiation injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(3):173-176.
点击复制

细胞因子在急性辐射损伤治疗中的作用(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
30
期数:
2006年第3期
页码:
173-176
栏目:
放射生物学
出版日期:
1900-01-01

文章信息/Info

Title:
Effects of cytokine on acute radiation injury
作者:
苗莉 缪竞诚
215123 苏州, 苏州大学医学院细胞分子生物学教研室
Author(s):
MIAO Li MIAO Jing-cheng
Department of Cell and Molecular Biology, Soochow University, Suzhou 215123, China
关键词:
造血细胞生长因子辐射损伤造血干细胞动员
Keywords:
Hematopoietic cell growth factorsRadiation injuryHematopoietic stem cell mobilization
分类号:
R818.05
摘要:
急性辐射损伤以及肿瘤患者在放疗或化疗后,均可发生程度不等的骨髓功能抑制。一些细胞因子通过刺激不同分化时期、不同类型的靶细胞影响其增殖和分化,从而对骨髓造血细胞起辐射防护和促进骨髓造血恢复的作用。随着基因工程的发展,人们可以获得越来越多的高纯度重组造血因子,这些因子在急性辐射损伤的实验研究和临床救治中发挥了极其重要的作用。同时,细胞因子治疗也存在一些问题,有待进一步研究和解决。
Abstract:
Acute radiation injury as well as radiotherapy and chemotherapy of tumor can lead to different extents of bone marrow aplasia. Some cytokines play an important role in cell proliferation and differentiation by stimulating types of target cells which are at different stages, so that they can protect hematopoietic cells from radiation and improve hematopoiesis. With the development of gene engineering technology, more and more high purity recombinant hematopoietic factors can be caquired, which is vital in the experimental research and clinical therapy of acute radiation injury. Meanwhile, further researches are required to solve the problems in cytokine-based therapy.

参考文献/References:

1 Waselenko JK, MacVittie TJ, Blakely WF, et al. Medical management of the acute radiation syndrome:recommendations of the strategic national stockpile radiation working group. Ann Intern Med, 2004, 140(12):1037-1051.
2 Dainiak N, Waselenko JK, Armitage JO, et al. The hematologist and radiation casualties. Hematol Am Soc Hematal Educ Program,2003. 473-496.
3 Liu YJ, Lu SH, Xu B, et al. Hemangiopoietin, a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages. Blood, 2004, 103(12):4449-4456.
4 Herodin F, Drouet M. Cytokine-based treatment of accidentally irradiated victims and new approaches. Exp Hematol, 2005, 33(10):1071-1080.
5 DorrW, Noack R, Spekl K, et al. Modification of oral mucositits by keratinocyte growth factor:, single radiation exposure. Int J Radiat Biol, 2001, 77(3):341-347.
6 Singh VK, Yadav VS. Role of cytokines and growth factors in radioprotection. Exp Mol Pathol, 2005, 78(2):156-169.
7 Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol, 2002, 30(6):513-528.
8 Drouet M, Mathieu J, Grenier N, et al. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, Flt-3 Ligand, TPO and IL-3 in combination resulted in CD34+ cell proliferation and differentiation. Stem Cells, 1999, 17(5):273-285.
9 Min D, Taylor PA, Panoskaltsis-Mortari A, et al. Protection from thymic epithelial cell injury by keratinocyte growth factor:a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood, 2002, 99(12):4592-4600.
10 罗庆良, 柳晓兰, 郝静, 等.大剂量全身照射比格狗生物效应观察.军事医学科学院院刊,2002,26(1):14.
11 Drouet M, Mourcin F, Grenier N, et al. Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression:logterm follow-up of hematopoiesis. Blood, 2004, 103(3):878-885.
12 罗庆良, 从玉文, 郝静, 等.造血因子与急性放射病.解放军医学杂志,2005,30(3):186-190.
13 Farese AM, Hunt P, Grab LB, et al. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation induced marrow aplasia. J Clin Invest, 1996, 97(9):2145-2151.
14 Mason KA, Komaki R, Cox JD, et al. Biology-based combined-modality radiotherapy:workshop report. Int J Radiat Oncol Biol Phys, 2001, 50(4):1079-1089.
15 Van der MeerenA, Mouthon MA, Gaugler MH, et al. Administration of recombinant human interleukin-11 after supralethal radiation exposure promotes survival in mice:interactive effect with thrombopoietin. Radiat Res, 2002, 157(6):642-649.

相似文献/References:

[1]包明月,刘玉龙.应用间充质干细胞治疗急性辐射损伤的研究现状与进展[J].国际放射医学核医学杂志,2016,40(1):65.[doi:10.3760/cma.j.issn.1673-4114.2016.01.013]
 Bao Mingyue,Liu Yulong.Recent advances in the application of mesenchymal stem cells for treatment of acute radiation injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):65.[doi:10.3760/cma.j.issn.1673-4114.2016.01.013]
[2]贺欣,储小飞,罗丹,等.穿心莲药物对辐射损伤效应影响的初步研究[J].国际放射医学核医学杂志,2015,39(5):375.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 005]
 he xin,chu xiaofei,luo dan,et al.exploration of andrographolide effects on radiation injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):375.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 005]
[3]路璐,张俊伶,李德冠,等.6 gy 137cs γ射线照射对小鼠造血功能损伤的动态观察研究[J].国际放射医学核医学杂志,2015,39(5):393.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 009]
 lu lu*,zhang junling,li deguan,et al.effects of 6 gy 137cs γ-irradiattion on the hematopoietic system of mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):393.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 009]
[4]刘惠惠,李险峰.放射性心脏损伤诊断和防治的临床研究进展[J].国际放射医学核医学杂志,2016,40(5):374.[doi:10.3760/cma.j.issn.1673-4114.2016.05.008]
 Liu Huihui,Li Xianfeng.Clinical research progress in diagnosis,prevention and treatment of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):374.[doi:10.3760/cma.j.issn.1673-4114.2016.05.008]
[5]张倩如,李海涛,田红旗.小分子辐射防护药物的研究进展[J].国际放射医学核医学杂志,2016,40(5):394.[doi:10.3760/cma.j.issn.1673-4114.2016.05.012]
 Zhang Qianru,Li Haitao,Tian Hongqi.Small molecule compounds against radiation:research advances[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):394.[doi:10.3760/cma.j.issn.1673-4114.2016.05.012]
[6]王浩,沈秀,靳瑾,等.“四物汤”对辐射危害的辅助保护作用研究[J].国际放射医学核医学杂志,2015,39(2):121.[doi:10.3760/cma.j.issn.1673-4114.2015.02.004]
 Wang Hao,Shen Xiu,Jin Jin,et al.Protective activity of Siwu Decoction against radiation hazards[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):121.[doi:10.3760/cma.j.issn.1673-4114.2015.02.004]
[7]曹婉婷,李浣洋,陈雪英,等.正常组织在放射治疗中并发的迟发性损伤[J].国际放射医学核医学杂志,2015,39(3):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
 Cao Wanting,Li Huanyang,Chen Xueying,et al.Late effects of radiotherapy on normal tissue[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
[8]陈雪梅,周树云,范源,等.表没食子儿茶素没食子酸酯对131I辐射损伤所致甲减大鼠模型抗氧化体系的保护作用[J].国际放射医学核医学杂志,2015,39(4):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
 Chen Xuemei,Zhou Shuyun,Fan Yuan,et al.Protection of antioxidant system of EGCG on the thyroid in rat model from 131I radiation damage[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
[9]李德冠,路璐,吴红英,等.G-CSF联合SB203580对4Gy照射小鼠免疫系统的作用[J].国际放射医学核医学杂志,2014,38(4):216.[doi:10.3760/cma.j.issn.1673-4114.2014.04.002]
 Li Deguan,Lu Lu,Wu Hongying,et al.The effects of G-CSF combined with SB203580 on the immune system of mice received 4 Gy total body irradiation[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):216.[doi:10.3760/cma.j.issn.1673-4114.2014.04.002]
[10]张洪明,李险峰.放射性心脏损伤动物模型的研究进展[J].国际放射医学核医学杂志,2014,38(6):412.[doi:10.3760/cma.j.issn.1673-4114.2014.06.015]
 Zhang Hong-ming,Li Xian-feng.Progress in animal model of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):412.[doi:10.3760/cma.j.issn.1673-4114.2014.06.015]
[11]邢志伟,姜恩海,王桂林,等.《造血刺激因子在急性放射病治疗中的应用规范》解读[J].国际放射医学核医学杂志,2012,36(4):234.[doi:10.3760/cma.j.issn.1673-4114.2012.04.010]
 XING Zhi-wei,JIANG En-hai,WANG Gui-lin,et al.Explanation of Application Standards of Hematopoietic Stimulating Factors in the Treatment of Acute Radiation Sickness[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(3):234.[doi:10.3760/cma.j.issn.1673-4114.2012.04.010]

备注/Memo

备注/Memo:
收稿日期:2006-02-25。
基金项目:国防科工委基础科研计划(K0102061501)
通讯作者:缪竞诚(E-mail:jcmiao@163.com)
更新日期/Last Update: 1900-01-01